SF
BEAT

Synovus Financial’s BioTelemetry, Inc. BEAT Stock Holding History

Synovus Financial’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,404
Closed -$54K – 2287
2020
Q1 		$54K Buy
+1,404
New +$64.6K ﹤0.01% 1096

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Synovus Financial's BEAT Position: Q2 2020 in Review

Synovus Financial sold out of BioTelemetry, Inc. (BEAT) in Q2 2020, closing a stake of 1,404 shares — an estimated $54K sold.

Synovus Financial first reported a position in BEAT in Q1 2020 and held it in 1 quarter. The position peaked at $54K in Q1 2020. 215 funds tracked by Wall St. Rank hold BEAT as of Q2 2020.

  • Synovus Financial reported no remaining BioTelemetry, Inc. position as of Q2 2020 after selling out during the quarter.
  • Synovus Financial sold 1,404 BioTelemetry, Inc. shares in Q2 2020, an estimated $54K.
  • Synovus Financial first reported a position in BioTelemetry, Inc. in Q1 2020 and held it in 1 quarter.
  • Synovus Financial's BioTelemetry, Inc. position peaked at $54K in Q1 2020.
  • 215 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2020.

Based on Synovus Financial's 13F filing for Q2 2020, filed 10 Aug 2020.